PsyBio Therapeutics Corp. PSYBF
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 75.13% | 58.98% | 55.66% | 37.54% | -- |
| Total Depreciation and Amortization | 50.00% | 300.00% | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -136.00% | -77.13% | -79.83% | -63.13% | -- |
| Change in Net Operating Assets | 260.56% | 470.55% | -8.52% | -127.32% | -- |
| Cash from Operations | 74.99% | 66.28% | 50.55% | -5.37% | -- |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -86.63% | 191.21% | 194.24% | 196.26% | -- |
| Cash from Investing | -86.63% | 191.21% | 198.89% | 199.29% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 50.00% | -100.00% | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -98.63% | -- | -- |
| Repurchase of Common Stock | 100.00% | 59.01% | 55.19% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 4,542.86% | -- | 99.23% | 99.23% | -- |
| Cash from Financing | 374.64% | 224.14% | -100.53% | -103.58% | -- |
| Foreign Exchange rate Adjustments | -81.82% | -150.00% | -16.67% | -96.55% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 92.25% | 99.84% | 122.64% | -57.05% | -- |